MaxCyte MXCT 深 沪
等待开盘 10-01 09:30:00 美东时间
1.12
-0.060
-5.08%
华盛通- 最 高1.20
- 今 开1.19
- 成交量 34.65万股
- 最 低 1.12
- 昨 收 1.18
- 总市值 1.16亿
- 52周最高 1.865
- 市盈率 静 --
- 换手率 0.34%
- 52周最低 0.6434
- 委 比 12.30%
- 总股本 1.03亿
- 历史最高 17.44
- 量 比 1.00
- 振 幅 6.78%
- 历史最低 0.6434
- 每 手 1
- 风险率 0.31%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多MaxCyte Appoints Sidharth Kapileshwar as Chief Corporate Development Officer
MaxCyte, Inc. has appointed Sidharth Kapileshwar as Chief Corporate Development Officer. Kapileshwar brings over 25 years of experience in corporate development, strategy, and innovation at global healthcare companies. He previously served as Vice President of Innovation at Danaher Corporation. MaxCyte specializes in cell engineering technologies for next-generation cell therapies.
09-23 12:05
MaxCyte Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
MaxCyte granted stock options and RSUs to Sidharth Kapileshwar upon his employment as Senior Vice-President and Chief Corporate Development Officer. The awards include options for 220,000 shares and RSUs for 110,000 shares, vesting over four years. The stock options have a 10-year term and an exercise price of $1.29, granted under the 2026 Inducement Plan.
09-11 20:30
MaxCyte (MXCT) 2026财年第二季度业绩电话会议：随着与基因泰克合作扩大重申业绩指引
MaxCyte 2026财年第二季度营收下降15%至730万美元，同时成本有所下降，公司维持了2026财年业绩指引。基因泰克（Genentech）和DTx将支撑下半年的增长。
08-14 08:31
MaxCyte Affirms FY2026 Sales Guidance of $30.000M-$32.000M vs $31.082M Est
MaxCyte (NASDAQ:MXCT) affirms FY2026 sales outlook from $30.000 million-$32.000 million to $30.000 million-$32.000 million vs $31.082 million estimate.
08-13 04:09
MaxCyte Q2 EPS $(0.08) Beats $(0.09) Estimate, Sales $7.271M Beat $6.475M Estimate
MaxCyte (NASDAQ:MXCT) reported quarterly losses of $(0.08) per share which beat the analyst consensus estimate of $(0.09) by 11.11 percent. This is a 33.33 percent increase over losses of $(0.12) per share from the same period last year. The company reported quarterly sales of $7.271 million which b...
08-13 04:09
Cisco, Alibaba And 3 Stocks To Watch Heading Into Wednesday
US stock futures mixed, Cisco and MaxCyte report positive earnings, Alibaba and Vishay to release results.
05-13 16:14
MaxCyte shares are trading higher after the company reported better-than-expected Q1 financial results.
MaxCyte shares are trading higher after the company reported better-than-expect...
05-13 04:58
Earnings Scheduled For May 12, 2026
Companies Reporting Before The Bell • Sionna Therapeutics (NASDAQ:SION) is proj...
05-12 19:11
美股大行评级 | 最高240美元，潜在涨幅53%！ARM获多家大行上调目标价；Braze 评级上演 “两极反转”，小摩、巴克莱上调，高盛、花旗下调
今日重点评级关注：HC Wainwright & Co.：维持OCUGEN"买入"评级，目标价从7美元升至10美元；HC Wainwright & Co.：维持Maze Therapeutics"买入"评级，目标价从60美元升至110美元
03-26 11:41
Craig-Hallum Maintains Buy on MaxCyte, Lowers Price Target to $5
Craig-Hallum analyst Matt Hewitt maintains MaxCyte (NASDAQ:MXCT) with a Buy and lowers the price target from $7 to $5.
03-26 00:24
